132 related articles for article (PubMed ID: 21896134)
1. Facial skin-lightening benefits of the tetrapeptide Pro-Lys-Glu-Lys on subjects with skin types V-VI living in South Africa.
Farwick M; Maczkiewitz U; Lersch P; Summers B; Rawlings AV
J Cosmet Dermatol; 2011 Sep; 10(3):217-23. PubMed ID: 21896134
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide.
Hakozaki T; Takiwaki H; Miyamoto K; Sato Y; Arase S
Skin Res Technol; 2006 May; 12(2):105-13. PubMed ID: 16626384
[TBL] [Abstract][Full Text] [Related]
4. Modulation of skin pigmentation by the tetrapeptide PKEK: in vitro and in vivo evidence for skin whitening effects.
Marini A; Farwick M; Grether-Beck S; Brenden H; Felsner I; Jaenicke T; Weber M; Schild J; Maczkiewitz U; Köhler T; Bonfigli A; Pagani V; Krutmann J
Exp Dermatol; 2012 Feb; 21(2):140-6. PubMed ID: 22142309
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
Bruce S
J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
[TBL] [Abstract][Full Text] [Related]
6. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
Grimes PE
J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
[TBL] [Abstract][Full Text] [Related]
7. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
[TBL] [Abstract][Full Text] [Related]
8. Natural ingredients for darker skin types: growing options for hyperpigmentation.
Alexis AF; Blackcloud P
J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
[TBL] [Abstract][Full Text] [Related]
9. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
10. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial.
Kimball AB; Kaczvinsky JR; Li J; Robinson LR; Matts PJ; Berge CA; Miyamoto K; Bissett DL
Br J Dermatol; 2010 Feb; 162(2):435-41. PubMed ID: 19845667
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
[TBL] [Abstract][Full Text] [Related]
12. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.
Hantash BM; Jimenez F
J Drugs Dermatol; 2009 Aug; 8(8):732-5. PubMed ID: 19663110
[TBL] [Abstract][Full Text] [Related]
13. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations.
Gold MH; Gallagher C
J Drugs Dermatol; 2013 Dec; 12(12):1468-72. PubMed ID: 24301250
[TBL] [Abstract][Full Text] [Related]
15. A double-blind vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females.
Katoulis A; Alevizou A; Soura E; Mantas N; Bozi E; Gregoriou S; Makris M; Rigopoulos D
J Cosmet Dermatol; 2014 Jun; 13(2):86-90. PubMed ID: 24910270
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
Hantash BM; Jimenez F
J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
[TBL] [Abstract][Full Text] [Related]
17. Skin lightening agents - Use or abuse? - A retrospective analysis of the topical preparations used by melasma patients of darker skin types.
Kandhari R; Khunger N
Indian J Dermatol Venereol Leprol; 2013; 79(5):701-2. PubMed ID: 23974587
[No Abstract] [Full Text] [Related]
18. Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging.
Fabi S; Massaki N; Goldman MP
J Drugs Dermatol; 2012 Aug; 11(8):964-8. PubMed ID: 22859242
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
[TBL] [Abstract][Full Text] [Related]
20. Skin lightening preparations and the hydroquinone controversy.
Draelos ZD
Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
